Key Details
Annual ROE
-177.55%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
May 15, 2024Recent annual earnings:
Mar 16, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
May 21, 2021Analyst ratings
Recent major analysts updates
Screeners with ONTX included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Similar stocks
Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Bruce Mackle - LifeSci Advisors, IR Steve Fruchtman - President and CEO Victor Moyo - Chief Medical Officer Mark Guerin - Chief Operating Officer and CFO Meena Arora - VP of Global Medical Affairs & Research and Development, Conference Call Participants Edouard Mullarky - Guggenheim Partners Ahu Demir - Ladenburg Thalmann Robert LeBoyer - Noble Capital Markets James Molloy - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by. Welcome to Onconova Therapeutics Third Quarter 2023 Financial Results and Business Update Conference Call.
NEWTOWN, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company intends to release its third quarter 2023 financial results on Tuesday, November 14, 2023.
Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Bruce Mackle - LifeSci Advisors, IR Dr. Steve Fruchtman - President and CEO Dr. Victor Moyo - Consultant Chief Medical Officer Mark Guerin - Chief Operating Officer and CFO Fred Frullo - Vice President, Regulatory Affairs and Quality Assurance Conference Call Participants Edouard Mullarky - Guggenheim Ahu Demir - Ladenburg Thalmann Robert LeBoyer - Noble Capital Markets Operator Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Second Quarter [Technical Difficulty] Dr. Steve Fruchtman Sarah, excuse me, you are coming in and out and I don't know if other people hear.
Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Bruce Mackle - Managing Director, LifeSci Advisors Steven Fruchtman - President and Chief Executive Officer Michael Saunders - Interim Chief Medical Officer Mark Guerin - Chief Operating Officer and Chief Financial Officer Conference Call Participants Joseph Pantginis - H.C. Wainwright Ahu Demir - Ladenburg Thalmann Robert LeBoyer - Noble Life Science Partners Operator Ladies and gentlemen, thank you for standing by.
Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.20 per share a year ago.
FAQ
- What is the primary business of Onconova Therapeutics?
- What is the ticker symbol for Onconova Therapeutics?
- Does Onconova Therapeutics pay dividends?
- What sector is Onconova Therapeutics in?
- What industry is Onconova Therapeutics in?
- What country is Onconova Therapeutics based in?
- When did Onconova Therapeutics go public?
- Is Onconova Therapeutics in the S&P 500?
- Is Onconova Therapeutics in the NASDAQ 100?
- Is Onconova Therapeutics in the Dow Jones?
- When was Onconova Therapeutics's last earnings report?
- When does Onconova Therapeutics report earnings?
- Should I buy Onconova Therapeutics stock now?